{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:24:28Z","timestamp":1791228268327,"version":"4.1.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s40121-016-0138-6","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T10:10:12Z","timestamp":1480414212000},"page":"85-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection"],"prefix":"10.1007","volume":"6","author":[{"given":"Alaa","family":"Badawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,29]]},"reference":[{"key":"138_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrmicro2714","volume":"10","author":"JD Radolf","year":"2012","unstructured":"Radolf JD, Caimano MJ, Stevenson B, Hu LT. Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol. 2012;10:87\u201399.","journal-title":"Nat Rev Microbiol"},{"key":"138_CR2","unstructured":"Center for Disease Control and Prevention. How many people get Lyme disease? http:\/\/www.cdc.gov\/lyme\/stats\/humancases.html (accessed, June 28, 2016)."},{"key":"138_CR3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","volume":"59","author":"AF Hinckley","year":"2014","unstructured":"Hinckley AF, Connally NP, Meek JI, Johnson BJ, Kemperman MM, Feldman KA, et al. Lyme disease testing by large commercial laboratories in the United. Clin Infect Dis. 2014;59:676\u201381.","journal-title":"Clin Infect Dis"},{"key":"138_CR4","unstructured":"Government of Canada. Lyme disease. http:\/\/www.healthycanadians.gc.ca (accessed: June 20, 2016)."},{"key":"138_CR5","first-page":"1086","volume":"85","author":"WF Wright","year":"2012","unstructured":"Wright WF, Riedel DJ, Talwani R. Diagnosis and management of lyme disease. Am Fam Phys. 2012;85:1086\u201393.","journal-title":"Am Fam Phys"},{"key":"138_CR6","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1056\/NEJMcp061181","volume":"354","author":"GP Wormser","year":"2006","unstructured":"Wormser GP. Clinical practice. Early Lyme disease. N Engl J Med. 2006;354:2794\u2013801.","journal-title":"N Engl J Med"},{"key":"138_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2334-9-79","volume":"9","author":"J Aucott","year":"2009","unstructured":"Aucott J, Morrison C, Munoz B, Rowe PC, Schwarzwalder A, West SK. Diagnostic challenges of early Lyme disease: lessons from a community case series. BMC Infect Dis. 2009;9:79. doi: 10.1186\/1471-2334-9-79 .","journal-title":"BMC Infect Dis"},{"key":"138_CR8","first-page":"993","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention. Three sudden cardiac deaths associated with Lyme carditis: United States, November 2012-July 2013. Morb Mortal Wkly Rep. 2013;62:993\u20136.","journal-title":"Morb Mortal Wkly Rep"},{"key":"138_CR9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089\u2013134.","journal-title":"Clin Infect Dis"},{"key":"138_CR10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1503\/cmaj.080148","volume":"180","author":"NH Ogden","year":"2009","unstructured":"Ogden NH, Lindsay LR, Morshed M, Sockett PN, Artsob H. The emergence of Lyme disease in Canada. Can Med Assoc J. 2009;180:1221\u20134.","journal-title":"Can Med Assoc J"},{"key":"138_CR11","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1586\/14787210.2014.940900","volume":"12","author":"DJ Cameron","year":"2014","unstructured":"Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther. 2014;12:1103\u201335.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"138_CR12","doi-asserted-by":"publisher","first-page":"e93243","DOI":"10.1371\/journal.pone.0093243","volume":"9","author":"MJ Soloski","year":"2014","unstructured":"Soloski MJ, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Aucott JN. Serum inflammatory mediators as markers of human Lyme disease activity. PLoS One. 2014;9:e93243. doi: 10.1371\/journal.pone.0093243 .","journal-title":"PLoS One"},{"key":"138_CR13","first-page":"91","volume":"9","author":"S Rahman","year":"2016","unstructured":"Rahman S, Shering M, Ogden NH, Lindsay R, Badawi A. Toll-like receptor cascade and gene polymorphism in host-pathogen interaction in Lyme disease. J Inflamm Res. 2016;9:91\u2013102.","journal-title":"J Inflamm Res"},{"key":"138_CR14","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/cid\/civ185","volume":"60","author":"CR Molins","year":"2015","unstructured":"Molins CR, Ashton LV, Wormser GP, Hess AM, Delorey MJ, Mahapatra S, et al. Development of a metabolic biosignature for detection of early Lyme disease. Clin Infect Dis. 2015;60:1767\u201375.","journal-title":"Clin Infect Dis"},{"key":"138_CR15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461\u201373.","journal-title":"Lancet"},{"key":"138_CR16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.idc.2007.12.012","volume":"22","author":"P Dandache","year":"2008","unstructured":"Dandache P, Nadelman RB. Erythema migrans. Infect Dis Clin North Am. 2008;22:235\u201360.","journal-title":"Infect Dis Clin North Am"},{"key":"138_CR17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","volume":"18","author":"ME Aguero-Rosenfeld","year":"2005","unstructured":"Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005;18:484\u2013509.","journal-title":"Clin Microbiol Rev"},{"key":"138_CR18","unstructured":"Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb Mortal Wkly Rep 1995; 44:590\u20131."},{"key":"138_CR19","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/cid\/civ735","volume":"61","author":"E Weitzner","year":"2015","unstructured":"Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, et al. Long-term assessment of post-treatment symptoms in patients with culture-confirmed early Lyme disease. Clin Infect Dis. 2015;61:1800\u20136.","journal-title":"Clin Infect Dis"},{"key":"138_CR20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1183\/09031936.00078812","volume":"42","author":"CE Wheelock","year":"2013","unstructured":"Wheelock CE, Goss VM, Balgoma D, Nicholas B, Brandsma J, Skipp PJ, et al. Application of omics technologies to biomarker discovery in inflammatory lung diseases. Eur Resp J. 2013;42:802\u201325.","journal-title":"Eur Resp J"},{"key":"138_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrg3316","volume":"14","author":"D Dulin","year":"2012","unstructured":"Dulin D, Lipfert J, Moolman MC, Dekker NH. Studying genomic processes at the single- molecule level: introducing the tools and applications. Nat Rev Genet. 2012;14:9\u201322.","journal-title":"Nat Rev Genet"},{"key":"138_CR22","doi-asserted-by":"crossref","unstructured":"Pielaat A, Barker GC, Hendriksen P, Peijnenburg A and Kuile BH. A foresight study on emerging technologies: State of the art of omics technologies and potential applications in food and feed safety. REPORT 1: Review on the state of art of omics technologies in risk assessment related to food and feed safety. EFSA supporting publication 2013: EN-495, 126\u00a0pp. (Available online: http:\/\/www.efsa.europa.eu\/publications ).","DOI":"10.2903\/sp.efsa.2013.EN-495"},{"key":"138_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4172\/2155-9899.1000250","volume":"5","author":"M Vranova","year":"2014","unstructured":"Vranova M, Halin C. Lymphatic vessels in inflammation. J Clin Cell Immunol. 2014;5:250. doi: 10.4172\/2155-9899.1000250 .","journal-title":"J Clin Cell Immunol"},{"key":"138_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4172\/2332-0877.1000149","volume":"2","author":"Y Ferrer-Acosta","year":"2014","unstructured":"Ferrer-Acosta Y, Gonz\u00e1lez M, Fern\u00e1ndez M, Washington AV. Emerging roles for platelets in inflammation and disease. J Infect Dis Ther. 2014;2:149. doi: 10.4172\/2332-0877.1000149 .","journal-title":"J Infect Dis Ther"},{"key":"138_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","volume":"16","author":"K Takeda","year":"2004","unstructured":"Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16:3\u20139.","journal-title":"Semin Immunol"},{"key":"138_CR26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.molimm.2003.10.005","volume":"40","author":"B Beutler","year":"2004","unstructured":"Beutler B. Innate immunity: an overview. Mol Immunol. 2004;40:845\u201359.","journal-title":"Mol Immunol"},{"key":"138_CR27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1126\/science.1115253","volume":"309","author":"J Choe","year":"2005","unstructured":"Choe J, Kelker MS, Wilson IA. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science. 2005;309:581\u20135.","journal-title":"Science"},{"key":"138_CR28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2796.2007.01821.x","volume":"261","author":"B Albiger","year":"2007","unstructured":"Albiger B, Dahlberg S, Henriques-Normark B, Normark S. Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors. J Intern Med. 2007;261:511\u201328.","journal-title":"J Intern Med"},{"key":"138_CR29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/1040841X.2012.706249","volume":"39","author":"S Kumar","year":"2013","unstructured":"Kumar S, Ingle H, Prasad DV, Kumar H. Recognition of bacterial infection by innate immune sensors. Crit Rev Microbiol. 2013;39:229\u201346.","journal-title":"Crit Rev Microbiol"},{"key":"138_CR30","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.4049\/jimmunol.157.10.4584","volume":"157","author":"RM Wooten","year":"1996","unstructured":"Wooten RM, Modur VR, McIntyre TM, Weis JJ. Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-kappa B and inflammatory activation in human endothelial cells. J Immunol. 1996;157:4584\u201390.","journal-title":"J Immunol"},{"key":"138_CR31","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1128\/IAI.62.9.3663-3671.1994","volume":"62","author":"Y Ma","year":"1994","unstructured":"Ma Y, Seiler KP, Tai KF, Yang L, Woods M, Weis JJ. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect Immun. 1994;62:3663\u201371.","journal-title":"Infect Immun"},{"key":"138_CR32","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1128\/IAI.61.9.3843-3853.1993","volume":"61","author":"Y Ma","year":"1993","unstructured":"Ma Y, Weis JJ. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun. 1993;61:3843\u201353.","journal-title":"Infect Immun"},{"key":"138_CR33","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.158.10.4838","volume":"158","author":"TB Morrison","year":"1997","unstructured":"Morrison TB, Weis JH, Weis JJ. Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils. J Immunol. 1997;158:4838\u201345.","journal-title":"J Immunol"},{"key":"138_CR34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1172\/JCI115966","volume":"90","author":"LC Miller","year":"1992","unstructured":"Miller LC, Isa S, Vannier E, Georgilis K, Steere AC, Dinareloo CA. Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist. J Clin Invest. 1992;90:906\u201312.","journal-title":"J Clin Invest"},{"key":"138_CR35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/eji.201040385","volume":"41","author":"M Oosting","year":"2011","unstructured":"Oosting M, Van de Veerdonk FL, Kanneganti TD, Strum P, Verschueren I, Berende A, et al. Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism. Eur J Immunol. 2011;41:172\u201381.","journal-title":"Eur J Immunol"},{"key":"138_CR36","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.4049\/jimmunol.0901390","volume":"183","author":"MM Petzke","year":"2009","unstructured":"Petzke MM, Brooks A, Krupna MA, Mordue D, Schwartz I. Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J Immunol. 2009;183:5279\u201392.","journal-title":"J Immunol"},{"key":"138_CR37","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1096\/fasebj.6.7.1532945","volume":"6","author":"R Porat","year":"1992","unstructured":"Porat R, Poutsiaka DD, Miller LC, Granowitz EV, Dinarello CA. Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi stimulated IL-8 synthesis in human mononuclear cells. FASEB J. 1992;6:2482\u20136.","journal-title":"FASEB J"},{"key":"138_CR38","doi-asserted-by":"publisher","unstructured":"Salazar JC, Duhnam-Ems S, La Vake C, Cruz AR, Moore MW, Caimano MJ et al. Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta. PLoS Pathog 2009; 5. doi: 10.1371\/journal.ppat.1000444 .","DOI":"10.1371\/journal.ppat.1000444"},{"key":"138_CR39","first-page":"233","volume":"42","author":"M Oosting","year":"2016","unstructured":"Oosting M, Buffen K, van der Meer JWM, Netea MG, Joosten LAB. Innate immunity networks during infection with Borrelia burgdorferi. Crit Rev Microbiol. 2016;42:233\u201344.","journal-title":"Crit Rev Microbiol"},{"key":"138_CR40","doi-asserted-by":"publisher","unstructured":"Bachmann M, Horn K, Rudloff I, Goren I, Holdener M, Chrosten U, et al. Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1. PLoS Pathog 2010;6. doi: 10.1371\/journal.ppat.1001144 .","DOI":"10.1371\/journal.ppat.1001144"},{"key":"138_CR41","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1086\/652871","volume":"201","author":"M Oosting","year":"2010","unstructured":"Oosting M, Berende A, Sturm P, Ter Hofstede HJ, de Jong DJ, Kanneganti TD, et al. Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction. J Infect Dis. 2010;201:1849\u201358.","journal-title":"J Infect Dis"},{"key":"138_CR42","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/art.22441","volume":"56","author":"JJ Shin","year":"2007","unstructured":"Shin JJ, Glickstein LJ, Steere AC. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory Lyme arthritis. Arthritis Rheum. 2007;56:1325\u201335.","journal-title":"Arthritis Rheum"},{"key":"138_CR43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-291X(90)91734-A","volume":"167","author":"G Beck","year":"1990","unstructured":"Beck G, Benach JL, Habicht GS. Isolation, preliminary chemical characterization, and biological activity of Borrelia burgdorferi peptidoglycan. Biochem Biophys Res Commun. 1990;167:89\u201395.","journal-title":"Biochem Biophys Res Commun"},{"key":"138_CR44","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.71.6.3437-3442.2003","volume":"71","author":"MA Burchill","year":"2003","unstructured":"Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM, et al. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun. 2003;71:3437\u201342.","journal-title":"Infect Immun"},{"key":"138_CR45","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/CVI.00052-11","volume":"18","author":"J Kuo","year":"2011","unstructured":"Kuo J, Nardelli DT, Warner TF, Callister SM, Schell RF. Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol. 2011;18:1125\u201332.","journal-title":"Clin Vaccine Immunol"},{"key":"138_CR46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1086\/524022","volume":"46","author":"KL Jones","year":"2008","unstructured":"Jones KL, Muellegger RR, Means TK, Lee M, Glickstein LJ, Damle N, et al. Higher mRNA levels of chemokines and cytokines associated with macrophage activation in erythema migrans skin lesions in patients from the United States than in patients from Austria with Lyme borreliosis. Clin Infect Dis. 2008;46:85\u201392.","journal-title":"Clin Infect Dis"},{"key":"138_CR47","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1002\/art.23972","volume":"58","author":"G Codolo","year":"2008","unstructured":"Codolo G, Amedei A, Steere AC, Papinutto E, Cappon A, Polenghi A, et al. Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. Arthritis Rheum. 2008;58:3609\u201317.","journal-title":"Arthritis Rheum"},{"key":"138_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1742-2094-8-36","volume":"8","author":"AJ Henningsson","year":"2011","unstructured":"Henningsson AJ, Tjernberg I, Malmvall BE, Forsberg P, Ernerudh J. Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study. J Neuroinflammation. 2011;8:36. doi: 10.1186\/1742-2094-8-36 .","journal-title":"J Neuroinflammation"},{"key":"138_CR49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(97)00118-5","volume":"79","author":"C Ekerfelt","year":"1997","unstructured":"Ekerfelt C, Ernerudh J, Bunikis J, Vrethem M, Aagesen J, Roberg M, et al. Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-\u03b3 predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes. J Neuroimmunol. 1997;79:155\u201362.","journal-title":"J Neuroimmunol"},{"key":"138_CR50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/IAI.67.1.140-147.1999","volume":"67","author":"GH Giambartolomei","year":"1990","unstructured":"Giambartolomei GH, Dennis VA, Lasater BL, Philipp MT. Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immun. 1990;67:140\u20137.","journal-title":"Infect Immun"},{"key":"138_CR51","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1189\/jlb.72.3.503","volume":"72","author":"TJ Lisinski","year":"2002","unstructured":"Lisinski TJ, Furie MB. Interleukin-10 inhibits proinflammatory activation of endothelium in response to Borrelia burgdorferi or lipopolysaccharide but not interleukin-1beta or tumor necrosis factor alpha. J Leukoc Biol. 2002;72:503\u201311.","journal-title":"J Leukoc Biol"},{"key":"138_CR52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-5728(02)00255-2","volume":"131","author":"M Grusell","year":"2002","unstructured":"Grusell M, Widhe M, Ekerfelt C. Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis. J Neuroimmunol. 2002;131:173\u20138.","journal-title":"J Neuroimmunol"},{"key":"138_CR53","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1128\/IAI.65.8.3107-3111.1997","volume":"65","author":"I Kang","year":"1997","unstructured":"Kang I, Barthold SW, Persing DH, Bockenstedt LK. T-helpercell cytokines in the early evolution of murine Lyme arthritis. Infect Immun. 1997;65:3107\u201311.","journal-title":"Infect Immun"},{"key":"138_CR54","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1086\/382893","volume":"189","author":"M Widhe","year":"2004","unstructured":"Widhe M, Jarefors S, Ekerfelt C, Vrethem M, Bergstrom S, Forsberg P, et al. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J Infect Dis. 2004;189:1881\u201391.","journal-title":"J Infect Dis"},{"key":"138_CR55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1684\/ecn.2009.0179","volume":"21","author":"A Berende","year":"2010","unstructured":"Berende A, Oosting M, Kullberg BJ, Netea MG, Joosten LA. Activation of innate host defense mechanisms by Borrelia. Eur Cytokine Netw. 2010;21:7\u201318.","journal-title":"Eur Cytokine Netw"},{"key":"138_CR56","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1128\/IAI.00394-08","volume":"76","author":"AL Bernardino","year":"2008","unstructured":"Bernardino AL, Myers TA, Alvarez X, Hasegawa A, Philipp MT. Toll-like receptors: insights into their possible role in the pathogenesis of Lyme neuroborreliosis. Infect Immun. 2008;76:4385\u201395.","journal-title":"Infect Immun"},{"key":"138_CR57","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/art.20337","volume":"50","author":"S Batsford","year":"2004","unstructured":"Batsford S, Dunn J, Mihatsch M. Outer surface lipoproteins of Borrelia burgdorferi vary in their ability to induce experimental joint injury. Arthritis Rheum. 2004;50:2360\u20139.","journal-title":"Arthritis Rheum"},{"key":"138_CR58","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jlb.65.2.162","volume":"65","author":"BK DuChateau","year":"1999","unstructured":"DuChateau BK, Munson EL, England DM, Lovrich SD, Callister SM, Jensen JR, et al. Macrophages interact with enriched populations of distinct T lymphocyte subsets for the induction of severe destructive Lyme arthritis. J Leukoc Biol. 1999;65:162\u201370.","journal-title":"J Leukoc Biol"},{"key":"138_CR59","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ni1002","volume":"4","author":"M Brigl","year":"2003","unstructured":"Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol. 2003;4:1230\u20137.","journal-title":"Nat Immunol"},{"key":"138_CR60","doi-asserted-by":"crossref","first-page":"30132","DOI":"10.1074\/jbc.M602057200","volume":"281","author":"JK Gautam","year":"2006","unstructured":"Gautam JK, Comeau LD, Krueger JK, Smith MF. Structural and functional evidence for the role of the TLR2 DD loop in TLR1\/TLR2 heterodimerization and signaling. J Biol Chem. 2006;281:30132\u201342.","journal-title":"J Biol Chem"},{"key":"138_CR61","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1002\/eji.200737034","volume":"37","author":"TR Hawn","year":"2007","unstructured":"Hawn TR, Misch E, Dunstan SJ, Thwaites GE, Lan NT, Quy HT, et al. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol. 2007;37:2280\u20139.","journal-title":"Eur J Immunol"},{"key":"138_CR62","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00005-013-0243-0","volume":"61","author":"JB Fraz\u00e3o","year":"2013","unstructured":"Fraz\u00e3o JB, Errante PR, Condino-Neto A. Toll-like receptors\u2019 pathway disturbances are associated with increased susceptibility to infections in humans. Arch Immunol Ther Exp (Warsz). 2013;61:427\u201343.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"138_CR63","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/art.34383","volume":"64","author":"K Strle","year":"2012","unstructured":"Strle K, Shin JJ, Glickstein LJ, Steere AC. Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis. Arthritis Rheum. 2012;64:1497\u2013507.","journal-title":"Arthritis Rheum"},{"key":"138_CR64","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.4049\/jimmunol.175.4.2534","volume":"175","author":"NW Schr\u00f6der","year":"2005","unstructured":"Schr\u00f6der NW, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V, et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol. 2005;175:2534\u201340.","journal-title":"J Immunol"},{"key":"138_CR65","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/art.34386","volume":"64","author":"TJ Sellati","year":"2012","unstructured":"Sellati TJ, Sahay B, Wormser GP. The toll of a TLR1 polymorphism in Lyme disease: a tale of mice and men. Arthritis Rheum. 2012;64:1311\u20135.","journal-title":"Arthritis Rheum"},{"key":"138_CR66","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/138920212803759712","volume":"13","author":"YT Lin","year":"2012","unstructured":"Lin YT, Verma A, Hodgkinson CP. Toll-like receptors and human diseases: lessons from single nucleotide polymorphisms. Curr Genom. 2012;13:633\u201345.","journal-title":"Curr Genom"},{"key":"138_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fcimb.2014.00055","volume":"4","author":"JL Cervantes","year":"2014","unstructured":"Cervantes JL, Hawley KL, Benjamin SJ, Weinerman B, Luu SM, Salazar JC. Phagosomal TLR signaling upon Borrelia burgdorferi infection. Front Cell Infect Microbiol. 2014;4:55. doi: 10.3389\/fcimb.2014.00055 .","journal-title":"Front Cell Infect Microbiol"},{"key":"138_CR68","doi-asserted-by":"publisher","first-page":"e25998","DOI":"10.1371\/journal.pone.0025998","volume":"6","author":"M Oosting","year":"2011","unstructured":"Oosting M, Ter Hofstede H, Sturm P, Adema GJ, Kullberg B-J, van der Meer JWM, et al. TLR1\/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes. PLoS One. 2011;6:e25998. doi: 10.1371\/journal.pone.0025998 .","journal-title":"PLoS One"},{"key":"138_CR69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0027-5107(01)00292-5","volume":"499","author":"MJ Aardema","year":"2002","unstructured":"Aardema MJ, MacGregor JT. Toxicology and genetic toxicology in the new era of \u201ctoxicogenomics\u201d: impact of \u201c-omics\u201d technologies. Mutat Res. 2002;499:13\u201325.","journal-title":"Mutat Res"},{"key":"138_CR70","doi-asserted-by":"publisher","first-page":"e00100","DOI":"10.1128\/mBio.00100-16","volume":"7","author":"J Bouquet","year":"2016","unstructured":"Bouquet J, Soloski MJ, Swei A, Cheadle C, Federman S, Billaud JN, et al. Longitudinal transcriptome analysis reveals a sustained differential gene expression signature in patients treated for acute Lyme disease. MBio. 2016;7:e00100\u201316. doi: 10.1128\/mBio.00100-16 .","journal-title":"MBio"},{"key":"138_CR71","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/08923973.2012.742535","volume":"35","author":"SH Park","year":"2013","unstructured":"Park SH, Moon Y. Integrated stress response-altered proinflammatory signals in mucosal immune-related cells. Immunopharmacol Immunotoxicol. 2013;35:205\u201314.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"138_CR72","doi-asserted-by":"publisher","first-page":"e1001289","DOI":"10.1371\/journal.ppat.1001289","volume":"7","author":"MF Fontana","year":"2011","unstructured":"Fontana MF, Banga S, Barry KC, Shen X, Tan Y, Luo ZQ, et al. Secreted bacterial effectors that inhibit host protein synthesis are critical for induction of the innate immune response to virulent Legionella pneumophila. PLoS Pathog. 2011;7:e1001289. doi: 10.1371\/journal.ppat.1001289 .","journal-title":"PLoS Pathog"},{"key":"138_CR73","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.micinf.2003.11.014","volume":"6","author":"ME Embers","year":"2004","unstructured":"Embers ME, Ramamoorthy R, Philipp MT. Survival strategies of Borrelia burgdorferi, the etiologic agent of Lyme disease. Microbes Infect. 2004;6:312\u20138.","journal-title":"Microbes Infect"},{"key":"138_CR74","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.micinf.2006.08.014","volume":"8","author":"JA Livengood","year":"2006","unstructured":"Livengood JA, Gilmore RD Jr. Invasion of human neuronal and glial cells by an infectious strain of Borrelia burgdorferi. Microbes Infect. 2006;8:2832\u201340.","journal-title":"Microbes Infect"},{"key":"138_CR75","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.imbio.2008.07.008","volume":"213","author":"O Sharif","year":"2008","unstructured":"Sharif O, Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology. 2008;213:701\u201313.","journal-title":"Immunobiology"},{"key":"138_CR76","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1128\/IAI.05451-11","volume":"79","author":"A Gautam","year":"2011","unstructured":"Gautam A, Dixit S, Philipp MT, Singh SR, Morici LA, Kaushal D, et al. Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation. Infect Immun. 2011;79:4876\u201392.","journal-title":"Infect Immun"},{"key":"138_CR77","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u2206\u2206CT method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"138_CR78","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cfg.82","volume":"2","author":"O Fiehn","year":"2001","unstructured":"Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp Funct Genom. 2001;2:155\u201368.","journal-title":"Comp Funct Genom"},{"key":"138_CR79","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.imbio.2007.11.003","volume":"213","author":"NW Schr\u00f6der","year":"2008","unstructured":"Schr\u00f6der NW, Eckert J, St\u00fcbs G, Schumann RR. Immune responses induced by spirochetal outer membrane lipoproteins and glycolipids. Immunobiology. 2008;213:329\u201340.","journal-title":"Immunobiology"},{"key":"138_CR80","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2249.2005.02820.x","volume":"141","author":"J Sj\u00f6wall","year":"2005","unstructured":"Sj\u00f6wall J, Carlsson A, Vaarala O, Bergstr\u00f6m S, Ernerudh J, Forsberg P, et al. Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-\u03b1 and interleukin-12 in asymptomatic individuals in response to live spirochetes. Clin Exper Immunol. 2005;141:89\u201398.","journal-title":"Clin Exper Immunol"},{"key":"138_CR81","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1359-6101(96)00031-7","volume":"7","author":"M Pasparakis","year":"1996","unstructured":"Pasparakis M, Alexopoulou L, Douni E, Kollias G. Tumour necrosis factors in immune regulation: everything that\u2019s interesting is\u2026new! Cytokine Growth Factor Rev. 1996;7:223\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"key":"138_CR82","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1074-7613(03)00296-6","volume":"19","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines. new players in the regulation of T cell responses. Immunity. 2003;19:641\u20134.","journal-title":"Immunity"},{"key":"138_CR83","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.4049\/jimmunol.171.5.2660","volume":"171","author":"JC Salazar","year":"2003","unstructured":"Salazar JC, Pope CD, Sellati TJ, Feder HM Jr, Kiely TG, Dardick KR, et al. Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J Immunol. 2003;171:2660\u201370.","journal-title":"J Immunol"},{"key":"138_CR84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","volume":"28","author":"B Bottazzi","year":"2010","unstructured":"Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010;28:157\u201383.","journal-title":"Annu Rev Immunol"},{"key":"138_CR85","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1182\/blood-2005-11-011932","volume":"108","author":"C Shah","year":"2006","unstructured":"Shah C, Hari-Dass R, Raynes JG. Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood. 2006;108:1751\u20137.","journal-title":"Blood"},{"key":"138_CR86","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nri800","volume":"2","author":"T Fujita","year":"2002","unstructured":"Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol. 2002;2:346\u201353.","journal-title":"Nat Rev Immunol"},{"key":"138_CR87","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejcb.2011.09.008","volume":"91","author":"JG Bode","year":"2012","unstructured":"Bode JG, Albrecht U, Haussinger D, Heinrich PC, Schaper F. Hepatic acute phase proteins\u2013regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-kappaB-dependent signaling. Eur J Cell Biol. 2012;91:496\u2013505.","journal-title":"Eur J Cell Biol"},{"key":"138_CR88","doi-asserted-by":"crossref","unstructured":"Stricker RB1, Winger EE. Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. Immunol Lett. 2001;76:43\u20138.","DOI":"10.1016\/S0165-2478(00)00316-3"},{"key":"138_CR89","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000116362","volume":"146","author":"RC Shoemaker","year":"2008","unstructured":"Shoemaker RC, Giclas PC, Crowder C, House D, Glovsky MM. Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United States. Int Arch Allergy Immunol. 2008;146:255\u201361.","journal-title":"Int Arch Allergy Immunol"},{"key":"138_CR90","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/infdis\/167.2.392","volume":"167","author":"F Dressler","year":"1993","unstructured":"Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993;167:392\u2013400.","journal-title":"J Infect Dis"},{"key":"138_CR91","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/IAI.00189-06","volume":"74","author":"AJ Nowalk","year":"2006","unstructured":"Nowalk AJ, Gilmore RD Jr, Carroll JA. Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins. Infect Immun. 2006;74:3864\u201373.","journal-title":"Infect Immun"},{"key":"138_CR92","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1189\/jlb.0812370","volume":"93","author":"T Herjan","year":"2013","unstructured":"Herjan T, Novotny M, Hamilton TA. Diversity in sequence-dependent control of GRO chemokine mRNA half-life. J Leukoc Biol. 2013;93:895\u2013904.","journal-title":"J Leukoc Biol."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-016-0138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T03:05:39Z","timestamp":1692587139000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40121-016-0138-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,29]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["138"],"URL":"https:\/\/doi.org\/10.1007\/s40121-016-0138-6","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,29]]}}}